Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H16N2O |
Molecular Weight | 192.2575 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(C=CC=C1)N2CCNCC2
InChI
InChIKey=VNZLQLYBRIOLFZ-UHFFFAOYSA-N
InChI=1S/C11H16N2O/c1-14-11-5-3-2-4-10(11)13-8-6-12-7-9-13/h2-5,12H,6-9H2,1H3
1-(2-methoxyphenyl)piperazine is an effective blocker of striatal dopaminergic receptors in rat brain and is apparently the simplest chemical structure known to exert dopaminergic blocking activity. It is exhibited pronounced antihypertensive and weak sympatholytic activities in experimental animals. Blood pressure was also lowered in hypertensive patients and this effect was sometimes accompanied by a strong sedation, and after large repeated doses, by disorientation and stupor. In a filter paper bioassay 1-(2-methoxyphenyl)piperazine demonstrated acaricidal activity. 1-(2-methoxyphenyl)piperazine is a building block of many serotonergic and dopaminergic agents. Some of them have antidepressant activity.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2093868 Sources: https://www.ncbi.nlm.nih.gov/pubmed/33259 |
|||
35.0 nM [Ki] | |||
Target ID: P19327 Gene ID: 24473.0 Gene Symbol: Htr1a Target Organism: Rattus norvegicus (Rat) Sources: https://www.ncbi.nlm.nih.gov/pubmed/8893838 |
68.0 nM [Ki] | ||
Target ID: P50406 Gene ID: 3362.0 Gene Symbol: HTR6 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/15745826 |
1200.0 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. | 1993 Aug 25 |
|
Two routes to [11C-carbonyl]organo-isocyanates utilizing [11C]phosgene ([11C]organo-isocyanates from [11C]phosgene). | 2001 Nov |
|
Oxotechnetium 99mTcO[SN(R)S][S] complexes as potential 5-HT1A receptor imaging agents. | 2002 Nov |
|
Exposure to airborne isocyanates and other thermal degradation products at polyurethane-processing workplaces. | 2002 Oct |
|
Workplace monitoring of isocyanates using ion trap liquid chromatography/tandem mass spectrometry. | 2003 |
|
Evaluation of some aroxyethylamine derivatives for hypotensive properties and their affinities for adrenergic receptors. | 2003 Dec |
|
Investigation of the competitive rate of derivatization of several secondary amines with phenylisocyanate (PHI), hexamethylene-1,6-diisocyanate (HDI), 4,4'-methylenebis(phenyl isocyanate) (MDI) and toluene diisocyanate (TDI) in liquid medium. | 2003 Feb |
|
Novel oxorhenium and oxotechnetium MO(NS)(S)2 complexes in the development of 5-HT1A receptor imaging agents. | 2003 Jan 15 |
|
Biological monitoring of exposure to toluene diisocyanate. | 2004 Oct |
|
Characterisation of derivatised monomeric and prepolymeric isocyanates by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry and structural elucidation by tandem mass spectrometry. | 2005 |
|
Synthesis and characterization of novel "3 + 2" oxorhenium complexes, ReO[SNO][NN]. | 2006 Jul 10 |
|
Tape-strip sampling for measuring dermal exposure to 1,6-hexamethylene diisocyanate. | 2006 Jun |
|
Determination of airborne isocyanates generated during the thermal degradation of car paint in body repair shops. | 2006 Jun |
|
Validation of a diffusive sampling method for airborne low-molecular isocyanates using 4-nitro-7-piperazinobenzo-2-oxa-1,3-diazole-impregnated filters and liquid chromatography-tandem mass spectrometry. | 2006 Nov 17 |
|
Effects of humidity and filter material on diffusive sampling of isocyanates using reagent-coated filters. | 2006 Oct |
|
The synthesis of L-carvone and limonene derivatives with increased antiproliferative effect and activation of ERK pathway in prostate cancer cells. | 2006 Oct 1 |
|
Abstracts of papers presented at the 2007 pittsburgh conference. | 2007 |
|
Aniline in hydrolyzed urine and plasma--possible biomarkers for phenylisocyanate exposure. | 2008 Oct |
|
'Click' D(1) receptor agonists with a 5-HT(1A) receptor pharmacophore producing D(2) receptor activity. | 2009 Jul 15 |
|
3-(1-Adamant-yl)-1-{[4-(2-meth-oxy-phen-yl)piperazin-1-yl]meth-yl}-4-methyl-1H-1,2,4-triazole-5(4H)-thione. | 2010 Jun 23 |
|
Structure-dependent inhibition of the human α1β2γ2 GABAA receptor by piperazine derivatives: A novel mode of action. | 2015 Dec |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/33259
Rat: 150 uM/kg
Route of Administration:
Intraperitoneal
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1346
Created by
admin on Sat Dec 16 11:07:24 GMT 2023 , Edited by admin on Sat Dec 16 11:07:24 GMT 2023
|
PRIMARY | |||
|
81NJO1330A
Created by
admin on Sat Dec 16 11:07:24 GMT 2023 , Edited by admin on Sat Dec 16 11:07:24 GMT 2023
|
PRIMARY | |||
|
35386-24-4
Created by
admin on Sat Dec 16 11:07:24 GMT 2023 , Edited by admin on Sat Dec 16 11:07:24 GMT 2023
|
PRIMARY | |||
|
DTXSID40188871
Created by
admin on Sat Dec 16 11:07:24 GMT 2023 , Edited by admin on Sat Dec 16 11:07:24 GMT 2023
|
PRIMARY | |||
|
252-537-7
Created by
admin on Sat Dec 16 11:07:24 GMT 2023 , Edited by admin on Sat Dec 16 11:07:24 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)